Literature DB >> 35706763

A proportional-hazards model for survival analysis and long-term survivors modeling: application to amyotrophic lateral sclerosis data.

Tasnime Hamdeni1, Soufiane Gasmi2.   

Abstract

The majority of survival data are affected by explanatory variables. We develop a new regression model for survival data analysis. As an alternative to standard mixture models, another model is proposed to describe the eventual presence of a surviving fraction. The proposed models are based on the Marshall-Olkin extended generalized Gompertz distribution. A maximum-likelihood inference is presented in the presence of covariates and a censorship phenomenon. Explanatory variables are incorporated into the model through proportional-hazards to evaluate the effect of risk factors on overall survival under different assumptions. Parametric, semi-parametric, and non-parametric methods are applied to survival analysis of patients treated for amyotrophic lateral sclerosis. Interesting results about riluzole use and other treatment effects on patients' survival have been obtained.
© 2020 Informa UK Limited, trading as Taylor & Francis Group.

Entities:  

Keywords:  62Exx; 62Fxx; 62Jxx; 62Nxx; 62P10; Amyotrophic lateral sclerosis; defective modeling; parameter estimation; proportional-hazards

Year:  2020        PMID: 35706763      PMCID: PMC9041952          DOI: 10.1080/02664763.2020.1830954

Source DB:  PubMed          Journal:  J Appl Stat        ISSN: 0266-4763            Impact factor:   1.416


  12 in total

1.  The estimation of the proportion of patients cured after treatment for cancer of the breast.

Authors:  J L HAYBITTLE
Journal:  Br J Radiol       Date:  1959-11       Impact factor: 3.039

2.  Parametric versus non-parametric methods for estimating cure rates based on censored survival data.

Authors:  A B Cantor; J J Shuster
Journal:  Stat Med       Date:  1992-05       Impact factor: 2.373

3.  Modelling geographically referenced survival data with a cure fraction.

Authors:  Freda Cooner; Sudipto Banerjee; A Marshall McBean
Journal:  Stat Methods Med Res       Date:  2006-08       Impact factor: 3.021

Review 4.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

5.  New defective models based on the Kumaraswamy family of distributions with application to cancer data sets.

Authors:  Ricardo Rocha; Saralees Nadarajah; Vera Tomazella; Francisco Louzada; Amanda Eudes
Journal:  Stat Methods Med Res       Date:  2015-06-19       Impact factor: 3.021

6.  Defective regression models for cure rate modeling with interval-censored data.

Authors:  Vinicius F Calsavara; Agatha S Rodrigues; Ricardo Rocha; Vera Tomazella; Francisco Louzada
Journal:  Biom J       Date:  2019-03-14       Impact factor: 2.207

Review 7.  Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).

Authors:  Robert G Miller; J D Mitchell; Dan H Moore
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 8.  Deciphering death: a commentary on Gompertz (1825) 'On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies'.

Authors:  Thomas B L Kirkwood
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-04-19       Impact factor: 6.237

9.  Complete hazard ranking to analyze right-censored data: An ALS survival study.

Authors:  Zhengnan Huang; Hongjiu Zhang; Jonathan Boss; Stephen A Goutman; Bhramar Mukherjee; Ivo D Dinov; Yuanfang Guan
Journal:  PLoS Comput Biol       Date:  2017-12-18       Impact factor: 4.475

Review 10.  Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis.

Authors:  Michael Hinchcliffe; Alan Smith
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.